YUBNUB.NEWS
FDA Panel to Review Modernas New Flu Vaccine as Approval Decision Approaches
BY MIRABEL ODETAThe U.S. Food and Drug Administrations advisory panel is preparing to vote on whether the benefits of Modernas flu vaccine, mFlusiva, outweigh its potential risks in older adults.
0 Commenti 0 condivisioni 15 Views